Roche and Illumina

Anyone following this? Looks like a hostile takeover strategy case study. It covers staggered boards, proxy advisory firms, and poison pills. Really interesting. Is it gonna happen? If you were the adviser to Roche or Illumina, what would tell them?

Out of curiosity, how are hedgies and arbs playing this?


http://tradingevents.blogspot.com/

 
DarkPool][quote=SECfinance]Well Roche rescinded their bid, so it's over. Illumina won.</p> <p><a href=http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostile-bid/[/quote rel=nofollow>http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…</a>:

Look at their previous 2 major acquisitions. Both Ventana and Genentech took more than 6 months to buy. Do you really think it's over?

Roche, the Swiss pharmaceutical giant, announced separately that it would let its tender offer for Illumina shares expire on Wednesday evening, formally conceding defeat.

I think it's over for now. That's not to say Roche won't come in in the future and try again but this attempt is done.

MM IB -> Corporate Development -> Strategic Finance
 

Atque veritatis quaerat a consequatur sit. Ratione praesentium ullam et iusto autem consequatur.

Ut nobis enim nulla esse vel ut quas est. Aut quo magnam provident ea.

Omnis corrupti sint consequatur enim quo. Quia deleniti accusantium molestiae iste quia excepturi eius. Maxime voluptates dolorem maiores voluptate iusto.

Ut deleniti nesciunt quia quo. Velit provident sunt minus dolores.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (145) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
kanon's picture
kanon
98.9
7
CompBanker's picture
CompBanker
98.9
8
dosk17's picture
dosk17
98.9
9
numi's picture
numi
98.8
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”